Læknablaðið - 15.07.2008, Qupperneq 36

■ FRÆÐIGREINAR
Y F I R L I T
Heimildir
1. Sánchez-Juan PJ. Etiologic and diagnostic facets ofCreutzfeldt-
Jakob disease. The effect of genes and environment. Chapter
2.1 The "NEUROCJD" collaboration: CJD surveillance
systems and results in 10 countries. (dissertation). Rotterdam,
2007.
2. Will RG, Alperovitch A, Poser S, et al. Descriptive
epidemiology of Creutzfeldt-Jakob disease in six European
countries, 1993-1995. Ann Neurol 1998; 43: 763- 7.
3. Ladogana A, Puopolo M, Croes EA, et al. Mortality from
Creutzfeldt-Jakob disease and related disorders in Europe,
Australia and Canada. Neurol 2005; 64:1586-91.
4. Brown P, Gibbs CJ, Rodgers-Johnson P, et al. Human
spongiform encephalopathy: The National Instiutes of
Health series of 300 cases of experimentally transmitted
disease. Ann Neurol 1994; 35: 513-529.
5. Parchi P, Giese A, Capellari S, et al.Classification of
sporadic Creutzfeldt-Jakob disease based on molecular and
phenotypic analysis of 300 subjects. Ann Neurol 1999; 46:
224-33.
6. Prusiner SB. Novel proteinaceous infectious particles cause
scrapie. Science 1982; 216:136-44.
7. Oesch B, Westaway D, Wálchli M, et al. A cellular gene
encodes scrapie 27-30 protein. Cell 1985; 40: 735-46.
8. Bueler H, Fischer M, Lang Y, et al. Normal development
and behaviour of mice lacking the neuronal cell-surface PrP
protein. Nature 1992; 356: 577-82.
9. Ma J, Wollmann R, Lindquist S. Neurotoxicity and neuro-
degeneration when PrP accumulates in the cytosol. Science
2002; 298:1781-5.
10. Roucou X, Guo Qi, Zhang Y, Goodyer CG, LeBlanc AC.
Cytosolic prion protein is not toxic and protects against Bax-
mediated cell death in human primary neurons. J Biol Chem
2003; 278: 40877-81.
11. Bragason BT, Pálsdóttir A. Interaction of PrP with NRAGE,
a protein involved in neuronal apoptosis. Mol Cell Neurosci
2005; 29: 232-44.
12. Prusiner SB. Prions. Proc Natl Acad Sci USA1998; 95:13363-
83.
13. Weissmann C. The state of the prion. Nature Rev Microbiol
2004;2:861-71.
14. Bíieler HR, Aguzzi A, Sailer A, et al. Mice devoid of PrP are
resistant to scrapie. Cell 1993; 73:1339-47.
15. Kirby L, Birkett CR., Rudyk H, Gilbert IH, Hope J. In vitro
cell-free conversion of bacterial recombinant PrP to PrPres as
a model for conversion. J.Gen.Virol. 2003; 84:1013-1020.
16. Legname G, Baskakov IV, Nguyen H-OB, et al. Synthetic
mammalian prions. Science 2004; 305: 673-6.
17. Castilla J, Saá P, Hetz C, Soto C. In vitro generation of
infectious scrapie prions. Cell 2005; 121:195-206.
18. Pálsson PA. Rida (Scrapie) in Iceland and its epidemiology.
In: Prusiner SB and Hadlow WJ, eds Slow Transmissible
Diseases of the Nervous System. Vol 1 Academic Press, New
York, 1979: 357-66.
19. Hlíðar S. Riða - Polyencephalitis. í: Hlíðar S. Sauðfé og
Sauðfjársjúkdómar. Akureyri, Þorsteinn M. Jónsson, 1937:
92-102.
20. Sigurðarson S. Scrapie eller rida i Island. Norsk Vet Tidskr
2000; 112: 408-13.
21. Kahana E, Alter M, Braham J, Sofer D. Creutzfeldt-Jakob
disease: Focus among Libyan Jews in Israel. Science 1974;
183: 90-1.
22. Herzberg L, Herzberg BN, Gibbs Jr. CJ, Sullivan W, Amyx H,
Gajdusek DC. Creutzfeldt-Jakob disease: Hypothesis for high
incidence in Libyan Jews in Israel. Science 1974; 186: 848.
23. Alter M. Athugasemd við grein 22. Science 1974; 186: 848.
24. Collins S, Boyd A, Fletcher A, et al.Creutzfeldt-Jakob disease:
diagnostic utility of 14-3-3 protein immunodetection in
cerebrospinal fluid. J Clin Neurosci 2000; 7: 203-8.
25. Kovács GG, Gelpi E, Ströbel T, et al. Involvement of
the endosomal-lysosomal system correlates with regional
pathology in Creutzfeldt-Jakob disease. J Neuropath Exp
Neurol 2007; 66: 628-36.
26. O'Rourke KI, Baszler TV, Miller JM, Spraker TR, Sadler-
Riggleman I, Knowles DP. Monoclonal antibody F89/160.1.5.
defines a conserved epitope on the ruminant prion protein. J
Clin Microbiol 1998; 36:1750-5.
27. Georgsson G, Gísladóttir E, Ámadóttir S. Quantitative
assessment of the astrocytic response in natural scrapie of
sheep. J Comp Path 1993; 108: 229-40.
28. Brownwell B, Oppenheimer DR. An ataxic form of subacute
presenile polioencephalopathy (Creutzfeldt-Jakob disease). J
Neurol Neurosurg Psychiatry 1965; 28: 350-61.
29. Cooper SA, Murray KL, Heath CA, Will RG, Knight RSG.
Sporadic Creutzfeldt- Jakob disease with cerebellar ataxia
at onset in the UK. J Neurol Neurosurg Psychiatry 2006; 77:
1273-5.
30. Laplanche J-L, Delasnerie-Laupretre N, Brandel JP, et al.
Molecular genetics of prion diseases in France. Neurol 1994;
44: 2347-51.
31. Schulz-Schaeffer WJ, Giese A, Windl O, Kretzschmar
HA. Polymorphism at codon 129 of the prion proetein
gene determines cerebellar pathology in Creutzfeldt-Jakob
disease. Clin Neuropathol 1996; 15: 353-7.
32. Henry C, Lowman A, Will RG. Creutzfeldt- Jakob disease in
elderly people. Age Ageing 2002; 31: 7-10.
33. Murray K, Ritchie DL, Bmce M, et al.Sporadic Creutzfeldt-
Jakob disease in two adolescents. J Neurol Neurosurg
Psychiatry 2008; 79:14-8.
34. Budka H, Aguzzi A, Brown P, et al. Neuropathological
diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and
other human spongiform encephalopathies (prion diseases).
Brain Pathol 1995; 5: 459-66.
35. Georgsson G, Tryggvason T, Jónasdóttir AD, Guðmundsson
S, Þorgeirsdóttir S. Polymorphism of PRNP codons in the
normal Icelandic population. Acta Neurol Scand 2006; 113:
419-25.
36. Shibuya S, Higuchi J, Shin R-W, Tateishi J, Kitamoto T. Codon
219 lys allele of PRNP is not found in sporadic Creutzfeldt-
Jakob disease. Ann Neurol 1998; 43: 826-8.
37. Aguzzi A, Heikenwalder M, Miele G. Progress and problems
in the biology, diagnostics, and therapeutics of prion diseases.
J Clin Invest 2004; 114:153-160.
38. Jónsson G. Changes in food consumption in Iceland, 1770-
1940. Scand EconomHist Rev 1998; 46: 24-41.
39. Þorgeirsdóttir H. Per Capita Supply of Food in Iceland 1956-
1995. Master thesis (1999) Human Nutrition Department of
Food Science, Faculty of Science, University of Iceland.
40. Collinge J, Whitfield J, McKintosh E, et al. Kum in the 21st
century-an acquired human prion disease with very long
incubation periods. Lancet 2006; 367: 2068-74.
41. Þorgeirsdóttir S, Georgsson G, Reynisson E, Sigurðarson
S, Pálsdóttir A.Search for healthy carriers of scrapie: an
assessment of subclinical infection of sheep in an Icelandic
scrapie flock by three diagnostic methods and correlation
with PrP genotypes. Arch Virol 2002; 147: 709-22.
42. Georgsson G, Adolfsdóttir JA, Pálsdóttir A, Jömndsson E,
Sigurðarson S, Þorgeirsdóttir S. High incidence of subclinical
infection of lymphoid tissues in Scrapie affected sheep flocks.
Arch Virol 2008; 153: 637-44.
43. Gísladóttir H. íslensk matarhefð. Mál og menning, Reykjavík
1999.
44. Georgsson G, Sigurðarson S, Brown P. Infectious agent of
sheep scrapie may persist in the environment for at least 16
years. J Gen Virol 2006; 87: 3737-40.
45. Mohan J, Brown KL, Farquhar CF, Bmce ME, Mabbott NA.
Scrapie transmission following exposure through the skin is
dependent on follicular dendritic cells in lymphoid tissues. J
Dermatol Sci 2004; 35:101-11.
46. Chatelain J, Cathala F, Brown P, Raharison S, Court
L, Gajdusek DC. Epidemiologic comparisons between
Creutzfeldt-Jakob disease and scrapie in France during the
12-year period 1968-1979. J Neurol Sci 1981; 51: 329-37.
47. Wientjens DPWM, Davanipour Z, Hofman A, et al. Risk
factors for Creutzfeldt-Jakob disease: A reanalysis of case-
control studies. Neurol 1996; 46:1287-91.
48. Van Duijn CM, Delasnerie-Laupretre N, Masullo C, et al.
Case-control study of risk factors of Creutzfeldt-Jakob
Disease in Europe during 1993-95. Lancet; 352:1081-5.
49. Korczyn AD, Chapman J, Goldfarb LG, Brown P, Gajdusek
DC. A mutation in the prion protein gene in Creutzfeldt-
Jakob disease in Jewish patients of Libyan, Greek,
and Tunisian origin. Ann NY Acad Sci 1991; 640:171-6.1)
Kvennasviði, 2) myndgreiningarsviði Landspítala.
Grein móttekin 25.1.2008, samþykkt til birtingar 19.6.2008
548 LÆKNAblaðiö 2008/94